Chronic cough, defined as a cough persisting for more than eight weeks, presents a frequent challenge in clinical practice. Despite its prevalence, the complexities involved in diagnosing and managing this condition often result in suboptimal treatment outcomes.
Identifying the underlying cause of chronic cough is a complex process due to the multifactorial nature of potential triggers. The most common causes include gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and non-asthmatic eosinophilic bronchitis (NAEB). However, the overlapping symptomatology often complicates accurate diagnosis.
An organized, stepwise approach is essential for effective diagnosis. This includes a comprehensive patient history, physical examination, and judicious use of diagnostic tests. Empirical therapy based on the most likely cause can be a useful diagnostic tool, but care must be taken to avoid unnecessary treatments.
Management of chronic cough should be tailored to the identified cause. GERD-related coughs may respond to acid-suppressive therapy, while UACS may benefit from intranasal corticosteroids. NAEB typically requires inhaled corticosteroids. However, a significant proportion of patients may have unexplained or refractory chronic cough, necessitating a more nuanced approach involving behavioral therapies and neuromodulatory agents.
The complexity of chronic cough management calls for a multidisciplinary approach. Collaboration between pulmonologists, gastroenterologists, allergists, and speech-language pathologists can facilitate comprehensive management, improving patient outcomes.
Chronic cough is a multifaceted condition requiring a systematic approach to diagnosis and management. Embracing a comprehensive, multidisciplinary strategy can help clinicians navigate these complexities, improving patient care and outcomes. Continued research is crucial to further refine these approaches and expand our understanding of this challenging condition.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation